Journal of Toxicologic Pathology
Online ISSN : 1881-915X
Print ISSN : 0914-9198
ISSN-L : 0914-9198
Short communications
Hepatic CYP1A Induction in 3-Methylcholanthrene-Treated Transgenic Rats with Insufficient Blood Growth Hormone
Yoshiro TaniHideki YamamotoYoko KamaiNaoyuki MaedaTsunemichi HosokawaKunio Doi
Author information
JOURNAL FREE ACCESS

2001 Volume 14 Issue 2 Pages 151

Details
Abstract
We have shown that the Mini rat, a transgenic rat strain carrying the antisense transgene for rat growth hormone, is a useful model to investigate the role of growth hormone in the expression of hepatic microsomal cytochrome P450s (CYPs). However, the induction of CYP isoforms by hepatic enzyme inducers in Mini rats has not been investigated. We selected two enzyme inducers, 3-methylcholantherene (2 mg/kg/day, i.p.) and phenobarbital (5 mg/kg/day, p.o.), and administered them to male Mini rats and their parental strain, Wistar rats, for 3 days. Enzyme activity assays and immunohistochemistry showed no differences in the expressions of CYP1A and CYP2B between untreated Wistar and Mini rats. 3-Methylcholanthrene administration induced CYP1A in both strains, but the induction was significantly higher in the Mini rat liver than in the Wistar rat liver. Phenobarbital administration increased CYP2B activity in both strains by more than 20-fold over their respective controls. Although there was no difference in the CYP2B immunohistochemistry between the two strains given phenobarbital, the CYP2B activity of phenobarbital-treated Mini rats was significantly higher than that of phenobarbital-treated Wistar rats. These results suggest that growth hormone may play a role in the hepatic enzyme induction.
Content from these authors
© 2001 The Japanese Society of Toxicologic Pathology
Previous article Next article
feedback
Top